Lung cancer treatment has advanced significantly, with several treatment approaches available depending on the type of cancer, its stage, and the patient’s overall health. Options may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Understanding these options can help patients and their families have more informed discussions with their cancer specialist.
For patients exploring Lung Cancer Treatment in Ahmedabad, Dr. Vikesh Shah helps patients understand cancer treatment approaches based on their diagnosis and individual medical circumstances. Immunotherapy may be an option for certain patients, but its suitability depends on several clinical factors. A specialist’s assessment is important before deciding on a treatment plan.
What Is Lung Cancer?
Lung cancer develops when abnormal cells in the lungs grow uncontrollably and form a tumour. These cells may affect normal lung function and, in some cases, spread to other parts of the body. Lung cancer can develop in people with a history of smoking as well as in people who have never smoked.
Several factors may influence lung cancer risk, including tobacco exposure, second-hand smoke, air pollution, radon exposure, certain workplace substances, and family history. However, having a risk factor does not necessarily mean someone will develop the disease.
Common symptoms may include:
- A persistent or worsening cough
- Coughing up blood
- Chest discomfort or pain
- Shortness of breath
- Unexplained weight loss
- Persistent fatigue
- Recurrent respiratory infections
These symptoms can occur with other health conditions, too. Anyone experiencing concerning or persistent symptoms should seek medical evaluation rather than assuming they have lung cancer.
What Are the Different Types of Lung Cancer?
Lung cancer is generally divided into two main categories. Identifying the type is important because treatment recommendations can differ.
Non-Small Cell Lung Cancer (NSCLC)
Non-small cell lung cancer is the most common category and includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Treatment depends on the cancer stage, tumour characteristics, molecular findings, and the patient’s health.
Depending on these factors, treatment may involve surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, or a combination of approaches.
Small Cell Lung Cancer (SCLC)
Small cell lung cancer is a less common type that can grow and spread rapidly. Treatment often involves chemotherapy and may include radiation therapy or immunotherapy in selected situations.
The appropriate approach depends on the extent of the disease, the patient’s condition, and the available treatment options.
What Factors Determine Lung Cancer Treatment?
There is no single treatment plan that is suitable for every lung cancer patient. Before recommending treatment, a specialist considers several factors, including:
- Cancer type: Whether the diagnosis is NSCLC or SCLC.
- Cancer stage: Whether the disease is limited to the lungs or has spread to other areas.
- Tumour biomarkers: Specific biological features that may help identify suitable targeted therapies or immunotherapy options.
- Overall health: Existing medical conditions, lung function, and the patient’s ability to tolerate treatment.
- Previous treatment: Whether the cancer has already been treated and how it responded.
- Treatment goals: Whether the goal is to remove the cancer, control its growth, reduce symptoms, or improve quality of life.
These factors help guide decisions about lung cancer treatment in Ahmedabad and determine whether one treatment or a combination of therapies may be appropriate.
What Are the Treatment Options for Lung Cancer?
Treatment recommendations depend on the diagnosis and stage of the disease. A cancer specialist may consider one or more of the following approaches.
1. Surgery
Surgery may be considered for selected patients, particularly when the cancer can be removed safely and has not spread extensively. The type of surgery depends on the tumour’s location, size, and the patient’s lung function.
Surgery is not suitable for every lung cancer case, especially when the disease has spread beyond the area that can be removed.
2. Radiation Therapy
Radiation therapy uses high-energy radiation to damage cancer cells. It may be used as a primary treatment in certain situations, after surgery, alongside other treatments, or to relieve symptoms caused by cancer.
The role of radiation therapy depends on the cancer type, stage, location, and overall treatment plan.
3. Chemotherapy
Chemotherapy uses medicines to destroy cancer cells or slow their growth. It may be recommended before surgery, after surgery, alongside radiation therapy, or for advanced disease.
Possible side effects vary according to the medicines used and may include fatigue, nausea, changes in blood cell counts, hair loss, or an increased risk of infection. Supportive care can help manage treatment-related effects.
4. Targeted Therapy
Targeted cancer therapy focuses on particular molecular changes or proteins that help cancer cells grow. In some lung cancers, molecular testing can identify changes that may make a patient eligible for a specific targeted medicine.
Not every tumour has an actionable target, so testing is important before treatment decisions are made.
5. Immunotherapy
Cancer immunotherapy helps the body’s immune system recognise or attack cancer cells. Some immunotherapy medicines work by blocking proteins that cancer cells use to reduce immune activity.
Immunotherapy may be used alone or in combination with other treatments for certain types and stages of lung cancer. The decision depends on the diagnosis, biomarker results, previous treatment, and other clinical considerations.
Can Immunotherapy Be Considered for Lung Cancer?
Yes, immunotherapy can be considered for some lung cancer patients. It has become an important treatment option for selected cases of non-small cell lung cancer and small cell lung cancer.
However, immunotherapy is not appropriate for everyone. The likely benefit depends on the cancer subtype, stage, tumour biomarkers, previous treatment, and the patient’s overall health.
For example, PD-L1 testing may help guide the use of certain immune checkpoint inhibitors in some cases of non-small cell lung cancer. Molecular testing may also be needed to identify specific genetic changes that influence treatment selection.
A specialist may consider immunotherapy in different settings, such as:
- As an initial treatment for selected patients
- In combination with chemotherapy
- After certain other treatments
- As part of a treatment plan for advanced disease
The most suitable approach should be determined after reviewing diagnostic reports and discussing potential benefits, risks, and alternatives with the treating specialist.
How Does Immunotherapy Work for Lung Cancer?
The immune system normally identifies and responds to harmful cells. However, some cancer cells can evade immune detection by using mechanisms that reduce the immune response.
Certain immunotherapy medicines, known as immune checkpoint inhibitors, block proteins involved in this process. This may allow immune cells to recognise and attack cancer cells more effectively.
The response varies between patients. Some may experience meaningful disease control, while others may not benefit or may develop side effects requiring treatment. Immunotherapy is therefore selected according to individual clinical circumstances rather than used as a universal treatment.
Which Tests Help Determine Immunotherapy Eligibility?
Before recommending immunotherapy, a cancer specialist may review the patient’s biopsy results, imaging, medical history, and additional laboratory reports.
Biomarker Testing
Biomarker testing examines specific features of the tumour that may help guide treatment. Depending on the cancer type, this can include testing for genetic changes and proteins associated with treatment response.
The results may help doctors compare immunotherapy, targeted therapy, chemotherapy, and other options.
PD-L1 Testing
PD-L1 is a protein that can influence how cancer cells interact with the immune system. Testing the tumour for PD-L1 expression may help determine whether certain immunotherapy medicines are appropriate in particular clinical settings.
PD-L1 results are only one part of the assessment. A high or low result does not, by itself, determine every treatment decision.
Molecular Testing
Molecular testing looks for specific genetic changes in cancer cells. In non-small cell lung cancer, results may identify changes for which targeted medicines are available.
These findings can affect the order in which treatment options are considered. The tests required vary depending on the cancer subtype, stage, and clinical situation.
Immunotherapy vs. Chemotherapy for Lung Cancer: What Is the Difference?
Immunotherapy and chemotherapy work in different ways, although both may be used to treat lung cancer.
| Feature | Immunotherapy | Chemotherapy |
| How it works | Helps the immune system recognise or attack cancer cells | Uses medicines that damage or destroy cancer cells |
| Treatment selection | Depends on cancer type, clinical factors, and sometimes biomarkers | Depends on cancer type, stage, and treatment goals |
| Possible side effects | May cause immune-related inflammation affecting organs | May cause nausea, fatigue, hair loss, and changes in blood counts, depending on the drugs |
| Use with other treatments | May be combined with chemotherapy or other approaches in selected cases | May be combined with immunotherapy, radiation, or other treatments |
Neither treatment is universally better than the other. In some cases, a combination may be recommended; in others, one approach may be more appropriate. The decision should be based on clinical evidence and the individual patient’s diagnosis.
What Are the Possible Side Effects of Lung Cancer Immunotherapy?
Immunotherapy may cause side effects because activating the immune system can sometimes lead it to attack healthy tissues. These effects can vary in severity and may occur during treatment or after it has finished.
Possible immune-related side effects include:
- Skin rash or itching
- Diarrhoea or inflammation of the bowel
- Inflammation of the lungs, known as pneumonitis
- Liver inflammation
- Thyroid or other hormone-related problems
- Unusual fatigue
Not every patient experiences these effects, and other side effects may also occur. New or worsening symptoms should be reported promptly to the treating team. Breathing difficulties, severe diarrhoea, significant weakness, or other serious symptoms require urgent medical assessment.
Patients should not stop or delay treatment without discussing their concerns with their healthcare team.
How Is a Personalised Lung Cancer Treatment Plan Developed?
A personalised cancer treatment plan brings together the patient’s diagnosis, test results, health status, and treatment preferences. The process may include:
- Confirming the diagnosis: Reviewing biopsy and pathology reports to identify the cancer type.
- Determining the stage: Using appropriate imaging and other investigations to understand the extent of the disease.
- Reviewing biomarkers: Identifying molecular or protein markers that may affect treatment selection.
- Comparing treatment options: Considering surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, or combinations where appropriate.
- Discussing benefits and risks: Explaining expected outcomes, potential side effects, alternatives, and treatment goals.
- Monitoring response: Using follow-up appointments, imaging, and other assessments to evaluate how the cancer responds.
A personalised approach helps patients understand why a particular treatment is recommended and what alternatives may be available.
Lung Cancer Treatment in Ahmedabad: Understanding Your Treatment Options
Patients seeking Lung Cancer Treatment in Ahmedabad should look for an appropriate specialist assessment that takes their diagnosis and individual circumstances into account. Access to relevant diagnostic reports and a clear discussion of treatment options can help patients make informed decisions.
Dr. Vikesh Shah, MBBS, MD (AIIMS, New Delhi), focuses on cancer treatment discussions and immunotherapy-related options. The suitability of immunotherapy depends on the specific cancer diagnosis, stage, test results, previous treatments, and overall health.
Patients considering treatment can prepare for a consultation by bringing their biopsy reports, imaging results, previous treatment records, and biomarker reports, if available. These records can help the treating specialist understand the case and discuss potential next steps.
The goal is to identify treatment options that are medically appropriate, explain their possible benefits and risks, and support informed decision-making.
When Should You Consult a Cancer Specialist?
A cancer specialist should be consulted when lung cancer is suspected, diagnosed, or has progressed despite previous treatment. A review may also be useful when patients want to understand their pathology reports, biomarker results, or available treatment alternatives.
Consider arranging a consultation if:
- A biopsy or imaging report suggests lung cancer.
- You have received a new lung cancer diagnosis.
- Your doctor has recommended additional biomarker testing.
- You want to understand whether immunotherapy or targeted therapy may be an option.
- The cancer has progressed or returned after treatment.
- You want to discuss a second opinion before making a treatment decision.
Persistent cough, coughing up blood, unexplained weight loss, or ongoing breathing difficulties should also be medically evaluated. Severe breathing difficulty or significant coughing of blood requires urgent medical attention.
Frequently Asked Questions About Lung Cancer Treatment
Is immunotherapy effective for lung cancer?
Immunotherapy can benefit some lung cancer patients, but responses vary. Its suitability depends on factors such as cancer type, stage, biomarkers, overall health, and previous treatment.
Can immunotherapy be used for advanced lung cancer?
Yes, immunotherapy may be part of treatment for certain advanced lung cancers. It may be used alone or alongside other therapies, depending on the clinical situation and relevant test results.
Is immunotherapy suitable for every lung cancer patient?
No. Some patients may be better suited to chemotherapy, targeted therapy, radiation therapy, surgery, or a combination of treatments. A specialist must assess the available evidence for each case.
How do doctors determine eligibility for immunotherapy?
Doctors consider the cancer diagnosis, stage, biopsy and pathology findings, relevant biomarkers such as PD-L1, molecular test results where indicated, previous treatments, and the patient’s overall health.
What factors affect lung cancer treatment decisions?
Important factors include cancer type and stage, tumour location, biomarker findings, lung function, other medical conditions, previous treatment response, and the patient’s goals and preferences.
Where can I seek advice about lung cancer treatment in Ahmedabad?
You can arrange a consultation with a qualified cancer specialist to review your reports and discuss suitable treatment options. Dr. Vikesh Shah’s team can be contacted through the official website to enquire about a consultation.
Conclusion: Exploring Suitable Lung Cancer Treatment Options
Lung cancer treatment has several approaches, including surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. The right choice depends on the cancer subtype, stage, tumour biomarkers, previous treatment, and the patient’s overall health.
Immunotherapy can be an important option for selected patients, but it does not work for everyone. Accurate diagnosis, appropriate testing, and a personalised discussion with a cancer specialist are essential to understanding the potential benefits and risks.
If you are exploring Lung Cancer Treatment in Ahmedabad, consult Dr. Vikesh Shah to discuss your diagnosis, review relevant test results, and understand which treatment approaches may be appropriate for your condition.